Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.43p
   
  • Change Today:
      0.15p
  • 52 Week High: 40.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 347,036
  • Market Cap: £25.61m
  • RiskGrade: 479
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
95.35% above the market average95.35% above the market average95.35% above the market average95.35% above the market average95.35% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
11.89% below the market average11.89% below the market average11.89% below the market average11.89% below the market average11.89% below the market average
69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average69.23% below the sector average
Price Book Ratio
55.56% below the market average55.56% below the market average55.56% below the market average55.56% below the market average55.56% below the market average
2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average2.56% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
71.2% below the market average71.2% below the market average71.2% below the market average71.2% below the market average71.2% below the market average
30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average
Price Chg 3m
81.46% below the market average81.46% below the market average81.46% below the market average81.46% below the market average81.46% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
48.5% below the market average48.5% below the market average48.5% below the market average48.5% below the market average48.5% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average
Momentum 20
50.4% below the market average50.4% below the market average50.4% below the market average50.4% below the market average50.4% below the market average
19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average19.05% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
0.51% above the market average0.51% above the market average0.51% above the market average0.51% above the market average0.51% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
18.66% below the market average18.66% below the market average18.66% below the market average18.66% below the market average18.66% below the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
36.2% below the market average36.2% below the market average36.2% below the market average36.2% below the market average36.2% below the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average
Operating Profit Loss
7.69% below the market average7.69% below the market average7.69% below the market average7.69% below the market average7.69% below the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
32.61% below the market average32.61% below the market average32.61% below the market average32.61% below the market average32.61% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Cash
6.07% below the market average6.07% below the market average6.07% below the market average6.07% below the market average6.07% below the market average
15.56% above the sector average15.56% above the sector average15.56% above the sector average15.56% above the sector average15.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
24.64% below the market average24.64% below the market average24.64% below the market average24.64% below the market average24.64% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Buys 1y
23.44% above the market average23.44% above the market average23.44% above the market average23.44% above the market average23.44% above the market average
Sector averageSector averageSector averageSector averageSector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.02% above the market average65.02% above the market average65.02% above the market average65.02% above the market average65.02% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 8.43p
Change Today 0.15p
% Change 1.81 %
52 Week High 40.00
52 Week Low 8.00
Volume 347,036
Shares Issued 303.83m
Market Cap £25.61m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.48% below the market average32.48% below the market average32.48% below the market average32.48% below the market average32.48% below the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Price Trend
96.58% below the market average96.58% below the market average96.58% below the market average96.58% below the market average96.58% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
24.47% above the market average24.47% above the market average24.47% above the market average24.47% above the market average24.47% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 25-Jun-2025

Time Volume / Share Price
16:28 1,650 @ 8.52p
16:10 506 @ 8.28p
15:53 1,828 @ 8.28p
14:34 30,000 @ 8.51p
13:11 5,653 @ 8.00p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page